Abstract

This review summarizes current knowledge about the role of hereditary hypercoagulation factors predisposing to thrombophilia-associated recurrent fetal loss. Thrombophilias are a major cause of adverse pregnancy outcome, playing a role in the etiology of up to 40% of cases worldwide. Hereditary thrombophilic predispositions to recurrent pregnancy wastage include genetic lesions in blood coagulation factors II and V as well as natural anticoagulants antithrombin, protein C and protein S. Furthermore, these gene defects confer higher thrombophilia risk in combination. They, as well as the newly described annexin A5 gene M2 promoter allele are associated with repeated fetal loss. The review gives a concise description of the molecular defects arising from the genetic changes, of the role these factors play in the timing and definition of fetal loss, and risk estimates from available studies and meta-analyses. This knowledge is instrumental for a more precise assessment of individual risks for repeated fetal loss and should guide therapeutic strategies, where relevant. Since the average childbearing age increases in western societies, the importance of a timely diagnosis of fetal loss predisposition is increasing.

Highlights

  • This review summarizes current knowledge about the role of hereditary hypercoagulation factors predisposing to thrombophilia-associated recurrent fetal loss

  • It should be noted that the predisposing role of hereditary thrombophilic factors to venous thrombosis has been demonstrated in several clinical studies and associated risks are significant (Table 1)

  • The predispositions to recurrent fetal loss associated with these lesions have been identified in retrospective analyses of pregnancies of patients included in the European Prospective Cohort on Thrombophilia (EPCOT) study [10]

Read more

Summary

Heritable Thrombophilic Lesions

Pregnancy loss is a major problem of women’s health. About 1/5 of all women worldwide have suffered at least one abortion, and 1/20 have had two or more spontaneous pregnancy losses [1]. The predispositions to recurrent fetal loss associated with these lesions have been identified in retrospective analyses of pregnancies (at baseline) of patients included in the European Prospective Cohort on Thrombophilia (EPCOT) study [10]. This analysis demonstrated that women with familial thrombophilia had an increased risk for fetal loss, stillbirth. This is why it is necessary for recurrent fetal loss to a) precisely evaluate the role of newly identified hereditary thrombophilia risk factors with higher population incidence, such as M2/ANXA5 and b) check the efficiency of thromboprophylaxis for recurrent pregnancy loss (RPL) patients that are carriers of hereditary thrombophilia lesions in adequately powered and properly controlled clinical trials

Factor V Leiden
Hereditary Disorders
APC Resistance Not Related To Factor V Leiden
Factor II PTm
Normal population
Rising maternal age and growing fetal loss risk
Findings
Anticoagulant therapy in RPL patients with heritable thrombophilia

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.